Gene · 6607
Papers3,510
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 3,510
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Promoting expression in gene therapy: more is not always better. | EMBO Mol Med | 2024 | 38413837 | PubTator, text mining | PubMed |
| 5qSMA: standardised retrospective natural history assessment in 268 patients with four copies of SMN2. | J Neurol | 2024 | 38409538 | PubTator, text mining | PubMed |
| Assessment of Nuclear Gem Quantity for Evaluating the Efficacy of Antisense Oligonucleotides in Spinal Muscular Atrophy Cells. | Methods Protoc | 2024 | 38392683 | PubTator, text mining | PubMed |
| Establishment of a Pilot Newborn Screening Program for Spinal Muscular Atrophy in Saint Petersburg. | Int J Neonatal Screen | 2024 | 38390973 | PubTator, text mining | PubMed |
| NAIP Gene Deletion and SMN2 Copy Number as Molecular Tools in Predicting the Severity of Spinal Muscular Atrophy. | Biochem Genet | 2024 | 38388850 | PubTator, text mining | PubMed |
| Spinal muscular atrophy: Molecular mechanism of pathogenesis, diagnosis, therapeutics, and clinical trials in the Indian context. | J Biosci | 2024 | 38384244 | PubTator, text mining | PubMed |
| Synergistic Effect of an Antisense Oligonucleotide and Small Molecule on Splicing Correction of the Spinal Muscular Atrophy Gene. | Neurosci Insights | 2024 | 38379891 | PubTator, text mining | PubMed |
| RegistrAME: the Spanish self-reported patient registry of spinal muscular atrophy. | Orphanet J Rare Dis | 2024 | 38373977 | PubTator, text mining | PubMed |
| 'Reading the palm' - A pilot study of grip and finger flexion strength as an outcome measure in 5q spinal muscular atrophy. | Brain Dev | 2024 | 38331667 | PubTator, text mining | PubMed |
| All exons are not created equal-exon vulnerability determines the effect of exonic mutations on splicing. | Nucleic Acids Res | 2024 | 38324470 | PubTator, text mining | PubMed |
| Consensus from the Brazilian Academy of Neurology for the diagnosis, genetic counseling, and use of disease-modifying therapies in 5q spinal muscular atrophy. | Arq Neuropsiquiatr | 2024 | 38316428 | PubTator, text mining | PubMed |
| Validation of SMA screening kits with SMN1 gene analysis in a Turkish cohort. | Clin Chim Acta | 2024 | 38309554 | PubTator, text mining | PubMed |
| Repeated AAV9 Titer Determination in a Presymptomatic SMA Patient with Three SMN2 Gene Copies - A Case Report. | J Neuromuscul Dis | 2024 | 38306058 | PubTator, text mining | PubMed |
| Alternative splicing and related RNA binding proteins in human health and disease. | Signal Transduct Target Ther | 2024 | 38302461 | PubTator, text mining | PubMed |
| Integration of network pharmacology, molecular docking, and simulations to evaluate phytochemicals from Drymaria cordata against cervical cancer. | RSC Adv | 2024 | 38292259 | PubTator, text mining | PubMed |
| Carrier screening for spinal muscular atrophy in 22913 Chinese reproductive age women. | Mol Genet Genomic Med | 2024 | 38284446 | PubTator, text mining | PubMed |
| Targeted exome sequencing strategy (NeoEXOME) for Chinese newborns using a pilot study with 3423 neonates. | Mol Genet Genomic Med | 2024 | 38284445 | PubTator, text mining | PubMed |
| Bioinformatics of germline variant discovery for rare disease diagnostics: current approaches and remaining challenges. | Brief Bioinform | 2024 | 38271481 | PubTator, text mining | PubMed |
| Whole-genome sequencing in prenatally detected congenital malformations: prospective cohort study in clinical setting. | Ultrasound Obstet Gynecol | 2024 | 38268232 | PubTator, text mining | PubMed |
| Multidisciplinary team meetings in treatment of spinal muscular atrophy adult patients: a real-life observatory for innovative treatments. | Orphanet J Rare Dis | 2024 | 38268028 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6607/papers?page=17